Name: Chemoresistance in Glioblastoma. Understanding and Management
Price: 98601.00 CRC
Availability: InStock
Author: Dileep Kumar;Rohit, PhD. Sharma
ISBN: 9780443339103

portada Chemoresistance in Glioblastoma. Understanding and Management

Chemoresistance in Glioblastoma. Understanding and Management

Formato

Libro Físico

Editorial

Academic Press Inc

Autor

Dileep Kumar;Rohit, PhD. Sharma

Año

2025

N° páginas

418

Encuadernación

Tapa Blanda

Dimensiones

23.50 x 19.10 cm

ISBN13

9780443339103

Chemoresistance in Glioblastoma. Understanding and Management

Dileep Kumar;Rohit, Phd. Sharma (Autor) · Academic Press Inc · Tapa Blanda

Libro Nuevo Importado

Envío: 19 a 24 días háb.

₡ 98.601

Costos de importación y 13% IVA incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

₡ 98.601

Llega entre el 31 Jul y el 11 Ago a Costa Rica. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Chemoresistance in Glioblastoma. Understanding and Management"

Chemoresistance in Glioblastoma: Understanding and Management gives clear insights into the detailed characteristic aspects of glioblastoma disease and the different therapeutic targets that are employed in reducing resistance to chemotherapeutic agents. The book delves deep into the root causes of multidrug resistance and the quest for novel molecular targets among growth factors, receptors, signal transduction proteins, microRNAs, transcription factors, proto-oncogenes, and tumor suppressor genes. In addition, it gives insights on the pathological and molecular features of glioblastoma and the role of cancer stem cells in the resistance to chemo and immunotherapy. While designed as a comprehensive guide, the book also serves as a valuable reference for professionals seeking to deepen their understanding, refine their skills, and explore new avenues within chemoresistance.

Chemoresistance in Glioblastoma: Understanding and Management gives clear insights into the detailed characteristic aspects of glioblastoma disease and the different therapeutic targets that are employed in reducing resistance to chemotherapeutic agents. The book delves deep into the root causes of multidrug resistance and the quest for novel molecular targets among growth factors, receptors, signal transduction proteins, microRNAs, transcription factors, proto-oncogenes, and tumor suppressor genes. In addition, it gives insights on the pathological and molecular features of glioblastoma and the role of cancer stem cells in the resistance to chemo and immunotherapy.

While designed as a comprehensive guide, the book also serves as a valuable reference for professionals seeking to deepen their understanding, refine their skills, and explore new avenues within chemoresistance.